QIAGEN, LLC received a federal award currently valued at $376,900 from National Institutes of Health. CLINICAL INTERPRETATION OF GENOMIC VARIANTS FROM LARGE NEXT-GENERATION PANEL (NGS), WHOLE EXOME SEQUENCING AND WHOLE TRANSCRIPTOME SEQUENCING IN SUPPORT OF U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES (DHHS), NATIONAL INSTITUTES OF HEALTH (NIH), NATI